PubMed Health⌕ Search

Biomedical subjects

G Riley

Publications and source records attributed to G Riley.

76 records · Page 5Linked to original sources

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.

SB 242084 has a high affinity (pKi 9.0) for the cloned human 5-HT2C receptor and 100- and 158-fold selectivity over the closely related cloned human 5-HT2B and 5-HT2A subtypes respectively. SB 242084 had over 100-fold selectivity over a range of other 5-HT, dopamine and adrenergic receptors. In studies of 5-HT-stimulated phosphatidylinositol hydrolysis using SH-SY5Y cells stably expressing the cloned human 5-HT2C receptor, SB 242084 acted as an antagonist with a pKb of 9.3, which closely resembled its corresponding receptor binding affinity. SB 242084 potently inhibited m-chlorophenylpiperazine (mCPP, 7 mgkg i.p. 20 min pre-test)-induced hypolocomotion in rats, a model of in vivo central 5-HT2C receptor function, with an ID50 of 0.11 mg/kg i.p., and 2.0 mg/kg p.o. SB 242084 (0.1-1 mg/kg i.p.) exhibited an anxiolytic-like profile in the rat social interaction test, increasing time spent in social interaction, but having no effect on locomotion. SB 242084 (0.1-1 mg/kg i.p.) also markedly increased punished responding in a rat Geller-Seifter conflict test of anxiety, but had no consistent effect on unpunished responding. A large acute dose of SB 242084 (30 mg/kg p.o.) had no effect on seizure susceptibility in the rat maximal electroshock seizure threshold test. Also, while SB 242084 (2 and 6 mg/kg p.o. 1 hr pre-test) antagonized the hypophagic response to mCPP, neither acute nor subchronic administration of the drug, for 5 days at 2 or 6 mg/kg p.o. twice daily, affected food intake or weight gain. The results suggest that SB 242084 is the first reported selective potent and brain penetrant 5-HT2C receptor antagonist and has anxiolytic-like activity, but does not possess either proconvulsant or hyperphagic properties which are characteristic of mutant mice lacking the 5-HT2C receptor.

Aminopyridines↗

Satisfaction with care: do Medicare HMOs make a difference?

Differences in satisfaction with care and perceptions of doctor/patient interactions were compared for Medicare beneficiaries enrolled in health maintenance organizations (HMOs) and beneficiaries in the fee-for-service (FFS) sector (nonenrollees). After controlling for covariates, beneficiaries expressed satisfaction with their care, regardless of where they received it. However, HMO enrollees were more likely than nonenrollees were to be very satisfied with the costs of care and with getting care at one location. In contrast, for every components-of-care measure, nonenrollees were more likely than HMO enrollees were to indicate high satisfaction with the quality of interaction with their physicians.

Aged↗

Fateful faxes.

Explore the source record for details and available documents.

Contraceptives, Oral↗